Aptevo Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Aptevo Therapeutics's estimated annual revenue is currently $11.9M per year.
- Aptevo Therapeutics's estimated revenue per employee is $155,000
- Aptevo Therapeutics's total funding is $35M.
Employee Data
- Aptevo Therapeutics has 77 Employees.
- Aptevo Therapeutics grew their employee count by 8% last year.
Aptevo Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | EVP and Chief Operating Officer | Reveal Email/Phone |
2 | Chief Scientific Officer | Reveal Email/Phone |
Aptevo Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $0.9M | 6 | 0% | N/A | N/A |
#2 | $0.9M | 6 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $5.7M | 37 | 42% | N/A | N/A |
#5 | $1.4M | 18 | -10% | N/A | N/A |
#6 | $3.7M | 48 | -21% | $16M | N/A |
#7 | $1.1M | 7 | 0% | N/A | N/A |
#8 | $0.8M | 5 | -81% | N/A | N/A |
#9 | $2.5M | 16 | -27% | N/A | N/A |
#10 | $0.8M | 5 | -17% | N/A | N/A |
What Is Aptevo Therapeutics?
Aptevo Therapeutics is a biotech company primarily focused on bringing novel oncology and hematology therapeutics to market. We leverage the innovative ADAPTIRￃﾢ￢ﾀﾞￂﾢ platform technology, a unique approach to cancer immunotherapy, to improve outcomes for cancer patients. Based in Seattle, Washington, the company is proud of its empowering work environment, entrepreneurial culture, and proprietary platform technology. As a result, Aptevo has been able to attract some of the most innovative minds in the field. Many of our team members have notable experience with other pioneering biotech companies including Trubion, ZymoGenetics, Immunex, Dendreon, and VLST. At Aptevo Therapeutics, our core values of ownership and collaborationￃﾢ￢ﾂﾬ￢ﾀﾝcombined with a history of innovation, dedication, and developmentￃﾢ￢ﾂﾬ￢ﾀﾝare positioning Aptevo Therapeutics to develop the science of whatￃﾢ￢ﾂﾬ￢ﾄﾢs next in biotechnology.
keywords:N/A
$35M
Total Funding
77
Number of Employees
$11.9M
Revenue (est)
8%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Aptevo Therapeutics News
(NASDAQ:APVO), a clinical-stage biotechnology company focused on developing novel immuno-oncology therapeutics based on its proprietary ADAPTIR...
Aptevo is a clinical-stage biotechnology company focused on developing novel immuno-oncology therapeutics for the treatment of different...
Aptevo Therapeutics Inc. shares were up 23% at $6.45 after the company reported 2021 royalty revenue of $12.3 million, up from $4.3 million...
Other Companies in Seattle
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $18.9M | 77 | 7% | N/A |
#2 | $15.8M | 77 | 8% | N/A |
#3 | $27M | 77 | 1% | $13.4M |
#4 | $17.5M | 77 | 22% | $15M |
#5 | $11.9M | 77 | -7% | $16.3M |